Levity vs T2D.com
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Patients wanting all-inclusive branded GLP-1 pens and willing to pay premium cash prices.
- semaglutide
- $1,199/mobrand-name
- tirzepatide
- $1,299/mobrand-name
FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.
Before enrolling
Premium pricing, roughly 1,199 to 1,599 per month
Desk Score
Diabetic GLP-1 access.
- semaglutide
- From $999/molowest dose rung
- tirzepatide
- From $999/molowest dose rung
Before enrolling
No pricing published on the public website — must register to see costs
Our review of Levity gives it 76/100 (C), while our review of T2D.com gives it 51/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
76/100
C
51/100
C
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Levity | T2D.com |
|---|---|---|
| Semaglutide | $1,199/mobrand-nameFull plan terms$1,199/mo (all doses, bundle, brand-name) | From $999/molowest dose rungFull plan terms$999/mo (starting dose, compounded) |
| Tirzepatide | $1,299/mobrand-nameFull plan terms$1,299/mo (all doses, bundle, brand-name) | From $999/molowest dose rungFull plan terms$999/mo (starting dose, compounded) |
| Coverage | 36 states | 1 state |
| Brand-name | Brand-name option listed | Not confirmed here |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | Patients wanting all-inclusive branded GLP-1 pens and willing to pay premium cash prices. | Diabetic GLP-1 access. |
| Desk Score | 76/100C | 51/100C |
The verdict
Desk pick — LevityLevity has the higher Desk Score, but T2D.com may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Patients wanting all-inclusive branded GLP-1 pens and willing to pay premium cash prices.
FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.
Diabetic GLP-1 access.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Levity
- CoreAge Rx vs T2D.com
- Amazon One Medical vs Levity
- Curve vs T2D.com
- Gala Health vs Levity
- Mixx Health & Wellness vs T2D.com
Or see the full comparison hub and the complete ranking.